Details for 2017747004

Up to date per 01.05.2026

Actions

Title / Product Name

KRISTALLINE FORM VON 2-BUTOXY-7-(4-(PYRROLIDIN-1-YLMETHYL) BENZYL)-5H-PYRROLO[3,2-D]PYRIMIDIN-4-AMIN ALS TLR7-AGONIST, DESSEN HERSTELLUNGSVERFAHREN UND VERWENDUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017747004

EP Publication Number

3412672

E-Number

1290913

Language

PCT Number

CN17072891

Publication Date

12.12.2018 A

15.07.2020 B1

Registration Date

15.07.2020

AT Publication Date

15.08.2020

Application Date

04.02.2017

Registration Number

Priorities

05.02.2016

201610082029

IPC

C07D 487/04 20060101AFI20190607BHEP

Maximum Duration of Protection

04.02.2037

Owner

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.No. 369 Yuzhou South Road Haizhou District Lianyungang, Jiangsu 222062CN

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

DING, Zhaozhong288 Futezhong Road Pudong New Area Shanghai 200131CN

SUN, Fei288 Futezhong Road Pudong New Area Shanghai 200131CN

HU, Yinghu288 Futezhong Road Pudong New Area Shanghai 200131CN

ZHOU, Yilong288 Futezhong Road Pudong New Area Shanghai 200131CN

WANG, Zheng288 Futezhong Road Pudong New Area Shanghai 200131CN

ZHAO, RuiNo.369 Yuzhou South Rd. Haizhou District Lianyungang Jiangsu 222062CN

YANG, LingNo.369 Yuzhou South Rd. Haizhou District Lianyungang Jiangsu 222062CN

Information about Fees